Illumina, Inc. (FRA:ILU)

Market Cap	29.11B +118.1%
Revenue (ttm)	3.94B +4.9%
Net Income	722.48M -34.4%
EPS	4.71 -32.1%
Shares Out	n/a
PE Ratio	40.29
Forward PE	38.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	191.46
Previous Close	192.50
Day's Range	191.46 - 191.46
52-Week Range	75.83 - 192.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Laboratory Analytical Instruments
• Founded: 1998
• Employees: 8,625
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILU

Financial Performance

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error